Harvard Apparatus Regenerative Technology, Inc. (HRGN) Free cash flow 2016–2024
Harvard Apparatus Regenerative Technology, Inc. (HRGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.9MFY2024 · since FY2016: -$9.4M → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.9M | +30.2% |
| FY2023 | -$7.0M | -36.0% |
| FY2022 | -$5.1M | -94.5% |
| FY2021 | -$2.6M | +35.1% |
| FY2020 | -$4.0M | +34.6% |
| FY2019 | -$6.2M | +20.4% |
| FY2018 | -$7.8M | +30.3% |
| FY2017 | -$11.2M | -19.1% |
| FY2016 | -$9.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice